InChI
1S/C22H30Cl2N10.2ClH/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18;;/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34);2*1H
SMILES string
Cl.Clc1ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc2ccc(Cl)cc2)cc1
InChI key
WJLVQTJZDCGNJN-UHFFFAOYSA-N
grade
pharmaceutical primary standard
API family
chlorhexidine
manufacturer/tradename
EDQM
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
application(s)
pharmaceutical (small molecule)
format
neat
正在寻找类似产品? 访问 产品对比指南
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Chlorhexidine dihydrochloride EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
Other Notes
Sales restrictions may apply.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Daily chlorhexidine bathing and hospital-acquired infection.
Michael W Climo et al.
The New England journal of medicine, 368(24), 2332-2332 (2013-06-14)
Daily chlorhexidine bathing and hospital-acquired infection.
Anthony L Esposito
The New England journal of medicine, 368(24), 2330-2330 (2013-06-14)
Maristela Dutra-Correa et al.
The journal of adhesive dentistry, 15(3), 287-292 (2013-04-06)
This study tested the hypothesis that 2% chlorhexidine (CHX) does not affect the 18-month clinical performance of two dentin adhesives, XP Bond (XPB) and XENO V (XEN). A total of 120 noncarious cervical lesions (NCCL) were selected and assigned to
Patricia Conley et al.
Nursing, 43(7), 18-23 (2013-06-20)
Several studies have demonstrated that oral care with chlorhexidine gluconate (CHG) 0.12% solution reduces the incidence of ventilator-associated pneumonia (VAP) in mechanically ventilated patients with endotracheal tubes in the ICU. Minimal evidence shows the effectiveness of any oral care protocols
Daily chlorhexidine bathing and hospital-acquired infection.
Jean-Jacques Parienti et al.
The New England journal of medicine, 368(24), 2331-2331 (2013-06-14)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持